Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAM-AMIN-UAS: Tamsulosin and Aminophylline in Retrograde Intrarenal Surgery
NCT07623876Phase 2Recruiting
- Sponsor
- Beni Suef University
- Start
- May 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tamsulosin and aminophylline in nephrolithiasis (4 arms), sponsored by Beni Suef University. Primary endpoint: Successful First-Attempt 10/12 Fr Ureteral Access Sheath Placement. Started May 2026; status: recruiting.
02
Drugs
tamsulosinaminophylline
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT07623876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07623876.